Incretin-based weight loss drugs may also trim lean mass, meta-analysis finds
A meta-analysis of five phase 3 trials found that incretin-based therapies lowered DXA-measured lean body mass versus comparators, though certainty ...
A meta-analysis of five phase 3 trials found that incretin-based therapies lowered DXA-measured lean body mass versus comparators, though certainty ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine